Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients ( 2024;48:253-64) - Eun Young Lee (Diabetes & Metabolism Journal)